Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

Impact of body mass index on clinicopathological outcome and biochemical recurrence after radical prostatectomy.

Narita S, Mitsuzuka K, Yoneyama T, Tsuchiya N, Koie T, Kakoi N, Kawamura S, Kaiho Y, Ohyama C, Tochigi T, Yamaguchi T, Habuchi T, Arai Y.

Prostate Cancer Prostatic Dis. 2013 Sep;16(3):271-6. doi: 10.1038/pcan.2013.16. Epub 2013 Jun 11.

PMID:
23752230
2.

Is body mass index associated with pathological outcomes after radical prostatectomy in Korean men?

Lee SE, Lee WK, Jeong MS, Abdullajanov M, Kim DS, Park HZ, Jeong SJ, Yoon CY, Byun SS, Choe G, Hong SK.

BJU Int. 2011 Apr;107(8):1250-5. doi: 10.1111/j.1464-410X.2010.09592.x. Epub 2010 Sep 29.

3.

Body mass index is not a predictor of biochemical recurrence after radical prostatectomy in Dutch men diagnosed with prostate cancer.

Kok DE, van Roermund JG, Aben KK, van de Luijtgaarden MW, Karthaus HF, van Vierssen Trip OB, Kampman E, Alfred Witjes J, Kiemeney LA.

World J Urol. 2011 Oct;29(5):695-701. doi: 10.1007/s00345-010-0629-0. Epub 2010 Dec 16.

4.

Obesity is not associated with aggressive pathologic features or biochemical recurrence after radical prostatectomy.

Tomaszewski JJ, Chen YF, Bertolet M, Ristau BT, Woldemichael E, Nelson JB.

Urology. 2013 May;81(5):992-6. doi: 10.1016/j.urology.2012.10.080. Epub 2013 Feb 28.

PMID:
23453649
5.

Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy.

Amling CL, Riffenburgh RH, Sun L, Moul JW, Lance RS, Kusuda L, Sexton WJ, Soderdahl DW, Donahue TF, Foley JP, Chung AK, McLeod DG.

J Clin Oncol. 2004 Feb 1;22(3):439-45. Epub 2003 Dec 22.

PMID:
14691120
6.

The interaction of body mass index and race in predicting biochemical failure after radical prostatectomy.

Lee DJ, Ritch C, Desai M, Benson MC, McKiernan JM.

BJU Int. 2011 Jun;107(11):1741-7. doi: 10.1111/j.1464-410X.2010.09768.x. Epub 2010 Oct 13.

7.

Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy.

Koie T, Mitsuzuka K, Yoneyama T, Narita S, Kawamura S, Kaiho Y, Tsuchiya N, Tochigi T, Habuchi T, Arai Y, Ohyama C, Yoneyama T, Tobisawa Y.

Int J Clin Oncol. 2015 Feb;20(1):176-81. doi: 10.1007/s10147-014-0696-0. Epub 2014 Apr 29.

PMID:
24771079
9.

Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins.

Freedland SJ, Terris MK, Presti JC Jr, Amling CL, Kane CJ, Trock B, Aronson WJ; Search Database Study Group.

J Urol. 2004 Aug;172(2):520-4.

PMID:
15247719
10.

Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.

Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L.

BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30.

11.

Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group.

Freedland SJ, Aronson WJ, Kane CJ, Presti JC Jr, Amling CL, Elashoff D, Terris MK.

J Clin Oncol. 2004 Feb 1;22(3):446-53. Epub 2003 Dec 22.

PMID:
14691122
12.

Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression?

Pfitzenmaier J, Pahernik S, Tremmel T, Haferkamp A, Buse S, Hohenfellner M.

BJU Int. 2008 Nov;102(10):1413-8. doi: 10.1111/j.1464-410X.2008.07791.x. Epub 2008 Jun 4.

13.
14.

Influence of body mass index and total testosterone level on biochemical recurrence following radical prostatectomy.

Hisasue S, Yanase M, Shindo T, Iwaki H, Fukuta F, Nishida S, Muranaka T, Miyamoto S, Tsukamoto T, Takatsuka K.

Jpn J Clin Oncol. 2008 Feb;38(2):129-33. doi: 10.1093/jjco/hym162. Epub 2008 Feb 14.

PMID:
18281308
15.

Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.

Freedland SJ, Sun L, Kane CJ, Presti JC Jr, Terris MK, Amling CL, Moul JW, Aronson WJ.

BJU Int. 2008 Sep;102(8):969-74. doi: 10.1111/j.1464-410X.2008.07934.x. Epub 2008 Aug 7.

16.

Body mass index as a prognostic marker for biochemical recurrence in Dutch men treated with radical prostatectomy.

van Roermund JG, Kok DE, Wildhagen MF, Kiemeney LA, Struik F, Sloot S, van Oort IM, Hulsbergen-van de Kaa CA, van Leenders GJ, Bangma CH, Witjes JA.

BJU Int. 2009 Aug;104(3):321-5. doi: 10.1111/j.1464-410X.2009.08404.x. Epub 2009 Feb 11.

17.

Low body mass index is associated with adverse oncological outcomes following radical prostatectomy in Korean prostate cancer patients.

Koo KC, Yoon YE, Rha KH, Chung BH, Yang SC, Hong SJ.

Int Urol Nephrol. 2014 Oct;46(10):1935-40. doi: 10.1007/s11255-014-0729-7. Epub 2014 May 10.

PMID:
24817520
18.

Body mass index trends and role of obesity in predicting outcome after radical prostatectomy.

Motamedinia P, Korets R, Spencer BA, Benson MC, McKiernan JM.

Urology. 2008 Nov;72(5):1106-10. doi: 10.1016/j.urology.2008.04.021. Epub 2008 Jul 7.

PMID:
18602142
20.

Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy.

Kamat AM, Babaian K, Cheung MR, Naya Y, Huang SH, Kuban D, Babaian RJ.

J Urol. 2003 Nov;170(5):1860-3.

PMID:
14532793

Supplemental Content

Support Center